DINUTUXIMAB | B125516 | UNITED THERAP
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Mar. 10, 2027 | Active | Computed |
| 7-Year Orphan | Mar. 10, 2022 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12358946(manufacturing) · relevance 75/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
12 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.